AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,906 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr | ₹0.25 Cr |
What is the latest Total Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,906 Cr |
| Mar2024 | ₹2,582 Cr |
| Mar2023 | ₹2,244 Cr |
| Mar2022 | ₹2,040 Cr |
| Mar2021 | ₹0.25 Cr |
How is Total Liabilities of AARTI PHARMALABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,906 Cr | 12.56 | |
| Mar2024 | ₹2,582 Cr | 15.07 | |
| Mar2023 | ₹2,244 Cr | 10.01 | |
| Mar2022 | ₹2,040 Cr | 815,860.00 | |
| Mar2021 | ₹0.25 Cr | - | |
Compare Total Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,625.6 Cr | -2.3% | 2.6% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -2.3% |
2.6% |
24.4% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses